| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |